Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Non-Current Assets: 2018-2024

Historic Non-Current Assets for Bicycle Therapeutics (BCYC) over the last 7 years, with Dec 2024 value amounting to $17.2 million.

  • Bicycle Therapeutics' Non-Current Assets fell 44.58% to $11.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.4 million, marking a year-over-year decrease of 44.58%. This contributed to the annual value of $17.2 million for FY2024, which is 37.91% down from last year.
  • According to the latest figures from FY2024, Bicycle Therapeutics' Non-Current Assets is $17.2 million, which was down 37.91% from $27.7 million recorded in FY2023.
  • Bicycle Therapeutics' Non-Current Assets' 5-year high stood at $32.8 million during FY2022, with a 5-year trough of $3.6 million in FY2020.
  • For the 3-year period, Bicycle Therapeutics' Non-Current Assets averaged around $25.9 million, with its median value being $27.7 million (2023).
  • Its Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 393.18% in 2021, then tumbled by 37.91% in 2024.
  • Yearly analysis of 5 years shows Bicycle Therapeutics' Non-Current Assets stood at $3.6 million in 2020, then surged by 393.18% to $17.8 million in 2021, then soared by 84.20% to $32.8 million in 2022, then declined by 15.52% to $27.7 million in 2023, then tumbled by 37.91% to $17.2 million in 2024.